Identification of factors associated with the efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder.
Tsutomu NagaiTatsuya KuriharaHiroaki KoyaYukako NakanoSatoru SugisawaTakehiko SambeKeiko KishimotoMari KogoHaruhisa OtaAkira IwanamiNaoki UchidaPublished in: Neuropsychopharmacology reports (2022)
Knowledge of these factors will help healthcare professionals to predict the likely efficacy of Atomoxetine in a given patient before subscribing it, facilitating individualized pharmacotherapy for adult attention-deficit/hyperactivity disorder.